Matt Sargent, MBA ‘03

Matt has joined bioTheranostics, Inc., a leadingbioTheranostics logo provider of molecular diagnostic solutions for metastatic cancer, as its Breast Cancer Index commercialization leader. bioTheranostics has been expanding its management team as it seeks to grow its commercial reach and to launch its Breast Cancer IndexSM molecular test. Matt brings with him more than 16 years of life sciences experience, during which he has concentrated on molecular oncology diagnostics. Previously he served as vice president of oncology sales at Caris Life Sciences, in addition to holding sales and marketing positions at MedTrust Online and Exiqon Diagnostics.

Matt Sargent, MBA ‘03

Read About These Alumni:

Tagged on:     

Leave a Reply